BeOne Medicines (ONC) FCF Margin (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -848.00 |
| Dec 31, 2025 | -999.00 |
| Sep 30, 2025 | 872.00 |
| Jun 30, 2025 | 2,163.00 |
| Mar 31, 2025 | -3,734.00 |
| Dec 31, 2024 | 3,045.00 |
| Sep 30, 2024 | 2,758.00 |
| Jun 30, 2024 | 2,285.00 |
| Mar 31, 2024 | 6,158.00 |
| Dec 31, 2023 | -11,439.00 |
| Sep 30, 2023 | 8,797.00 |
| Jun 30, 2023 | 6,007.00 |
| Mar 31, 2023 | -2,455.00 |
| Dec 31, 2022 | 5,735.00 |
| Sep 30, 2022 | -4,703.00 |
| Jun 30, 2022 | -3,409.00 |
| Mar 31, 2022 | -19,555.00 |
| Dec 31, 2021 | 37,628.00 |
| Sep 30, 2021 | 4,094.00 |
| Jun 30, 2021 | -32,908.00 |
| Mar 31, 2021 | 43,404.00 |
| Dec 31, 2020 | -3,619.00 |
| Sep 30, 2020 | 2,962.00 |
| Jun 30, 2020 | 28,627.00 |
| Mar 31, 2020 | -12,248.00 |
| Dec 31, 2019 | -6,049.00 |
| Sep 30, 2019 | -47,509.00 |
| Jun 30, 2019 | 20,887.00 |
| Mar 31, 2019 | 3,900.00 |
| Dec 31, 2018 | 2,787.00 |
| Sep 30, 2018 | -9,724.00 |
| Jun 30, 2018 | 13,227.00 |
| Mar 31, 2018 | -100,554.00 |
| Dec 31, 2017 | 66,008.00 |
| Jun 30, 2016 | -286,917.00 |
| Mar 31, 2016 | -310,018.00 |
| Dec 31, 2015 | 53,193.00 |
| Sep 30, 2015 | -39,420.00 |
| Jun 30, 2015 | 4,732.00 |